IVIG, aspirin, and Kawasaki disease

被引：2

作者：

Morgan, GJ ^{[1
]}

MacLeod, C

Jenkins, J

Stewart, C

Craig, B

机构：

[1] Antrim Area Hosp, Dept Paediat, Antrim, Ireland

[2] Royal Belfast Hosp Sick Children, Dept Paediat Cardiol, Belfast, Antrim, North Ireland

来源：

JOURNAL OF PEDIATRICS | 2003年 / 143卷 / 02期

关键词：

D O I：

10.1067/S0022-3476(03)00276-2

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：280 / 281

页数：2

共 50 条

[31] IVIG-related haemolysis in Singaporean children with Kawasaki disease
Reactions Weekly, 2021, 1858 (1) : 6 - 6
[32] Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial
Portman, Michael A.
Dahdah, Nagib S.
Slee, April
Olson, Aaron K.
Choueiter, Nadine F.
Soriano, Brian D.
Buddhe, Sujatha
Altman, Carolyn A.
Del Toro, Kamill
Kourtidou, Soultana
Wisotzkey, Bethany
Bruce, Margaret
Cox, Jennifer
Williams, Richard
Reeder, Jamie
Kirkpatrick, Edward
Malloy, Marsha
Krolikowslki, Mary
Briere, Julie
Breault, Fabiola
Rajan, Sujatha
Mensch, Deborah
Stellato, Nancy
Rubin, Lorry
Sood, Sunil
Leibowitz, Jill
Shah, Rita
Soma, Vijaya
Cooper, Rubin
DeMers, Christine
Sexson-Tejtel, Sara K.
Griffin, Debra
Shittu, Teniola
Munjal, Iona
Balem, Kelly Ann
Imundo, Lisa
Isgro, Josephine
Ferris, Anne
Slee, April
PEDIATRICS, 2019, 143 (06)
[33] Is aspirin necessary in the acute phase of Kawasaki disease?
Huang, Xijing
Huang, Ping
Zhang, Li
Xie, Xiaofei
Xia, Shuliang
Gong, Fang
Yuan, Jia
Jin, Liling
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (06) : 661 - 664
[34] Does high dose aspirin treatment reduce retreatment with IVIG in acute Kawasaki's Syndrome?
Imundo, LF
Barasch, N
Geoghagon, M
Levy, DM
Altmann, K
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S535 - S535
[35] Aspirin Dose in Kawasaki Disease: The Ongoing Battle
Dhanrajani, Anita
Chan, Mercedes
Pau, Stephanie
Ellsworth, Janet
Petty, Ross
Guzman, Jaime
ARTHRITIS CARE & RESEARCH, 2018, 70 (10) : 1536 - 1540
[36] IVIg-related Hemolytic Anemia in Patients Treated for Kawasaki Disease
Lobo, R. Henrich
Pary, P. P.
Criss, V. R.
Luban, N. L.
Wong, E.
TRANSFUSION, 2014, 54 : 135A - 135A
[37] Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease
Kimura, Mitsuaki
Harazaki, Masashi
Fukuoka, Tetsuya
Asakura, Isao
Sakai, Hidemasa
Kamimaki, Tsutomu
Ohkawara, Ichiro
Akiyama, Naoe
Tsurui, Satoshi
Iwashima, Satoru
Shimomura, Masaki
Morishita, Hideaki
Meguro, Takaaki
Seto, Shiro
PEDIATRICS INTERNATIONAL, 2017, 59 (04) : 397 - 403
[38] Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand
Durongpisitkul, Kritvikrom
Sangtawesin, Chaisit
Khongphatthanayopthin, Apichai
Panamonta, Manat
Sopontammarak, Somkiat
Sittiwangkul, Rekwan
Pongpanich, Boonchob
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2006, 24 (01): : 27 - 32
[39] Whole Genome Sequencing to Identify Predictors of IVIG Response in Kawasaki Disease
Shrestha, Sadeep
Wiener, Howard
Kajimoto, Hidemi
Srinivasasainagendra, Vinodh
Ledee, Dolena
Chowdhury, Sabrina
Beckley, Mikayla
Padilla, Luz
Dahdah, Nagib
Tiwari, Hemant K.
Portman, Michael A.
CIRCULATION, 2022, 146
[40] IVIG-REFRACTORY KAWASAKI DISEASE: DISTILLING THE LITERATURE TO PREDICT OUTCOMES
Crayne, C.
Beukelman, T.
JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 581 - 581

← 1 2 3 4 5 →